Evidence map›Paper›PMID 42609583›Full record

ArticleResearch (Washington, D.C.)2026

Inhibition Mechanism of Pancreatic K

Tianyi Hou, Mengmeng Wang, Yongmei Tan, Chengpeng Fan, Lei Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tianyi HouState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Beijing Key Laboratory of Novel Antibodies and Multifunctional Conjugated Drugs, Peking University, Beijing 100871, China.
Mengmeng WangState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Beijing Key Laboratory of Novel Antibodies and Multifunctional Conjugated Drugs, Peking University, Beijing 100871, China.
Yongmei TanState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Beijing Key Laboratory of Novel Antibodies and Multifunctional Conjugated Drugs, Peking University, Beijing 100871, China.
Chengpeng FanSchool of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.
Lei ChenState Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Beijing Key Laboratory of Novel Antibodies and Multifunctional Conjugated Drugs, Peking University, Beijing 100871, China.ORCID https://orcid.org/0000-0002-7619-8311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pancreatic adenosine triphosphate (ATP)-sensitive potassium (K

Identifiers

PMID42609583
PMCPMC13478508

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.